Single Peptides · Exact presentation
AOD-9604 · 2 mg Vial
AOD-9604 · 2 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Dosing & Reconstitution Guide
For a 2 mg presentation, the reference concentration of 0.667 mg/mL mathematically corresponds to 2.999 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 0.667 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0067 mg at this concentration.
Standard / Gradual Approach (3 mL = ~0.667 mg/mL)
The source chart summarizes “300 mcg–500 mcg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Standard / Gradual Approach (3 mL = ~0.667 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–4 | 300 mcg | 45 units (0.45 mL) |
| Weeks 5–12 | 500 mcg | 75 units (0.75 mL) |
Reconstitution Steps
For a 2 mg presentation, the reference concentration of 0.667 mg/mL mathematically corresponds to 2.999 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 0.667 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0067 mg at this concentration.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
It is studied for metabolic signaling involving incretin receptors and, depending on the compound, amylin or glucagon. Activity differs across single, dual, and triple agonists.
Potential Benefits & Side Effects
Class-related considerations include gastrointestinal effects, measurement errors, and risks from unapproved products. A research vial is not automatically equivalent to an authorized medicine.
Source trail
Scientific references and source discovery
- PeptideDosages — exact AOD-9604 · 2 mg Vial entrysecondary-structure
- PubMed — literature search for AOD-9604primary-discovery
- ClinicalTrials.gov — study search for AOD-9604trial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference